1239506-69-4

Basic information

• Product Name: ethyl (1E)-N-(2,4,6-trimethylphenyl)sulfonyloxyethanimidate
• Synonyms: ethyl (1E)-N-(2,4,6-trimethylphenyl)sulfonyloxyethanimidate
• CAS NO: 1239506-69-4
• Molecular Weight: 285.364
• Mol File: 1239506-69-4.mol
• Article Data: 7

Chemical Properties

• CAS DataBase Reference: ethyl (1E)-N-(2,4,6-trimethylphenyl)sulfonyloxyethanimidate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl (1E)-N-(2,4,6-trimethylphenyl)sulfonyloxyethanimidate(1239506-69-4)
• EPA Substance Registry System: ethyl (1E)-N-(2,4,6-trimethylphenyl)sulfonyloxyethanimidate(1239506-69-4)

Safety Data

• Hazardous Substances Data: 1239506-69-4(Hazardous Substances Data)

Upstream product

• 773-64-8 2-mesitylenesulphonyl chloride 
• 20703-41-7 ethyl N-hydroxyacetimidate 
• 31767-15-4 ethyl (2E)‐2‐(hydroxyimino)acetate 

Downstream Products

• 36016-40-7 mesitylenesulfonylhydroxylamine 
• 1201762-87-9 1-amino-2-methylpyrazin-1-ium 2,4,6-trimethylbenzenesulfonate 
• 59247-63-1 1-amino-4-(methoxycarbonyl)pyridin-1-ium 2,4,6-trimethylbenzene-1-sulfonate 

Relevant articles and documents

Facile conversion of cysteine and alkyl cysteines to dehydroalanine on protein surfaces: Versatile and switchable access to functionalized proteins

An efficient and robust oxidative elimination of cysteine to dehydroalanine has been discovered. The reaction is induced by O-mesitylenesulfonylhydroxylamine (MSH) and is compatible with methionine. The key elimination has been executed on protein surfaces and allows ready access to different post-translationally modified proteins through conjugate addition of sulfur nucleophiles to dehydroalanine. Treatment of the resulting thioether with MSH results in regeneration of dehydroalanine, allowing a "functional switch" by subsequent addition of a different thiol. Copyright

ISOPROPYL TRIAZOLO PYRIDINE COMPOUNDS

The present invention provides a compound of the Formula (I) below: Wherein R1 is selected from the group consisting of H, CH3, CN, CH2CN, C(CH3)2CN, and F; R2 is selected from the group consisting of H, O(C1-C3alkyl)R5, CH2CN, and CN; R3 is selected from the group consisting of H, OCH3, CN, C(CH3)2CN, and CH2CN; R4 is selected from the group consisting of H and CH3; R5 is selected from the group consisting of H, CN, C(CH3)2CN, OCH3, S(O)2CH3, and C(CH3)2OH; provided that at least one selected from the group consisting of R1, R2, R3 and R4 is H; or a pharmaceutically acceptable salt thereof, methods of treating diabetes using the compound and a process for preparing the compound.

ISOPROPYL TRIAZOLO PYRIDINE COMPOUNDS

The present invention provides a compound of the Formula (I) below: Wherein R1 is selected from the group consisting of H, CH3, CN, CH2CN, C(CH3)2CN, and F; R2 is selected from the group consisting of H, O(C1-C3alkyl)R5, CH2CN, and CN; R3 is selected from the group consisting of H, OCH3, CN, C(CH3)2CN, and CH2CN; R4 is selected from the group consisting of H and CH3; R5 is selected from the group consisting of H, CN, C(CH3)2CN, OCH3, S(O)2CH3, and C(CH3)2OH; provided that at least one selected from the group consisting of R1, R2, R3 and R4 is H; or a pharmaceutically acceptable salt thereof, methods of treating diabetes using the compound and a process for preparing the compound.